DPP4 and acute lymphoblastic leukemia: It is a marker of aggressive disease for certain subsets of T-cell non-Hodgkin's lymphomas/leukemias where expression of CD26 on T-lymphoblastic lymphomas/acute lymphoblastic leukemia cells is associated with a worse outcome compared with CD26-negative tumors [14].